Literature DB >> 2107019

Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107019      PMCID: PMC1451875     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  23 in total

Review 1.  Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Campoli-Richards
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

Review 2.  Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

3.  Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections.

Authors:  D Gratton
Journal:  Int J Dermatol       Date:  1987-09       Impact factor: 2.736

4.  Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

Review 5.  Changing therapy for skin and soft tissue infections in children: have we come full circle?

Authors:  J L Blumer; E Lemon; J O'Horo; D J Snodgrass
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129

Review 6.  Topical antibiotics in dermatology.

Authors:  J V Hirschmann
Journal:  Arch Dermatol       Date:  1988-11

Review 7.  Topical mupirocin in the treatment of bacterial skin infections.

Authors:  J Rumsfield; D P West; I K Aronson
Journal:  Drug Intell Clin Pharm       Date:  1986-12

8.  Treatment of impetigo: a review.

Authors:  R S Baltimore
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct

9.  Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

Authors:  R L Hill; G J Duckworth; M W Casewell
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

10.  Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.

Authors:  J Goldfarb; D Crenshaw; J O'Horo; E Lemon; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.